Results 51 to 60 of about 23,091 (180)
Advanced Science, Volume 13, Issue 17, 23 March 2026.We analyzed long‐read genomic sequencing data obtained from 40 inbred mouse strains to produce a large database of structural variants. This dataset captures the major types of structural variants, which includes deletions, insertions, duplications, and inversions.
Wenlong Ren +6 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Background Non‐Hodgkin lymphoma (NHL) is increasingly prevalent in middle‐aged and elderly populations, contributing to the rising global health burden, particularly in high‐income countries. Methods This retrospective analysis utilized data from the Global Burden of Disease (GBD) study (1990–2021) to examine temporal trends in age ...
Yuecan Chen +12 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Background Carbohydrate antigen 19–9 (CA19‐9) is a cell surface glycoprotein widely used as a diagnostic and prognostic serum marker for monitoring pancreatic cancer. The aim of this study was to evaluate the prevalence and clinical relevance of CA19‐9 expression in human cancer. Methods To comprehensively determine the prevalence and clinical
Nina Schraps +31 more
wiley +1 more source
Targetable Vulnerabilities in MYC‐Driven B Cell Lymphomas Resistant to BCR Extinction
Hematological Oncology, Volume 44, Issue 2, March 2026.ABSTRACT Polatuzumab vedotin, an antibody‐drug conjugate (ADC) targeting the B cell receptor (BCR) signaling subunit CD79B, has recently entered frontline therapy for diffuse large B cell lymphoma (DLBCL) and high‐grade B cell lymphoma (HGBCL), achieving encouraging clinical results. However, MYC‐driven B cell lymphomas, particularly HGBCL with MYC and
Silvia Brambillasca +15 more
wiley +1 more source
Peritoneal Lymphomatosis as Posttransplant Lymphoproliferative Disorder
eJHaem, Volume 7, Issue 2, April 2026.
Shiori Nishitani +7 more
wiley +1 more source
Hematological Oncology, Volume 44, Issue 2, March 2026.ABSTRACT Post‐transplant lymphoproliferative disorder (PTLD) is a rare, dreaded complication of organ transplantation with major clinical challenges. We conducted a nationwide population‐based study of all solid organ transplant (SOT) recipients (n = 6555), both adults and children, over a 30‐year period in Finland.
Terhi K. Friman +11 more
wiley +1 more source
Multiple cranial nerve palsies in immunodeficiency subtype of Burkitt lymphoma
Journal of Community Hospital Internal Medicine Perspectives, 2018 Burkitt lymphoma is a late complication of HIV, and bilateral cranial nerve palsies are extremely rare in patients with AIDS. A twenty year old Caucasian male with known congenital HIV who had been non-adherent with anti-retroviral therapy presented with
Abbas Ali, Abhishek Kalla
doaj +1 more source
Infectious Agents and Cancer, 2007 Background The HIV epidemic has challenged our previous understanding of endemic Burkitt's lymphoma. Despite the strong association of Burkitt's lymphoma and HIV infection in the Developed world, and against previous postulations that the cancer is due ...
Lubega Joseph
doaj +1 more source
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
MedComm – Oncology, Volume 5, Issue 1, March 2026.One‐Carbon metabolism in T‐cell activation and tumor competition. T‐cell activation shifts metabolic pathways, promoting anabolic metabolism and bioenergetic capacity. One‐carbon metabolism plays a crucial role in histone and DNA methylation in activated T cells.
Yuting Jiang +3 more
wiley +1 more source
Abducens nerve palsy as initial presentation of Burkitt Lymphoma during Pregnancy Post–Cesarean abducens nerve paresis and Headache [PDF]
International Journal of Hematology-Oncology and Stem Cell Research, 2009 Burkitt’s lymphoma is one of the most hematologic malignancies that involve the central nervous system. Our patient had a rare presenting symptom of lymphoma during pregnancy. It is reasonable to search for Burkitt’s lymphoma in every
Farhad Shahi +3 more
doaj